LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis

Muhammad Danyal Ahsan / Sarah R. Levi / Emily M. Webster / Hannah Bergeron / Jenny Lin / Priyanka Narayan / Becky Baltich Nelson / Xuan Li / Rana K. Fowlkes / Jesse T. Brewer / Charlene Thomas / Paul J. Christos / Eloise Chapman-Davis / Evelyn Cantillo / Kevin Holcomb / Ravi N. Sharaf / Melissa K. Frey

PEC Innovation, Vol 2, Iss , Pp 100138- (2023)

2023  

Abstract: Purpose: To evaluate rates of familial disclosure of hereditary cancer syndrome information. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines (PROSPERO no.: CRD42020134276). Key electronic databases were ... ...

Abstract Purpose: To evaluate rates of familial disclosure of hereditary cancer syndrome information. Methods: A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines (PROSPERO no.: CRD42020134276). Key electronic databases were searched to identify studies evaluating hereditary cancer syndrome cascade relative disclosure. Eligible studies were subjected to meta-analysis. Results: Thirty-four studies met inclusion criteria. Among 11,711 included relatives, 70% (95% CI 60 - 78%) were informed of their risk of carrying a cancer-associated pathogenic variant; of 2,875 relatives informed of their risk who were evaluated for uptake of cascade testing, 43% (95% CI 27 - 61%) completed testing. Rates of disclosure were higher among female vs male relatives (79% [95% CI 73% - 84%] vs 67% [95% CI 57% - 75%]) and first-degree vs second-degree relatives (83% [95% CI 77% - 88%] vs 58% [95% CI 45 – 69%]). Conclusion: Nearly one-third of at-risk relatives remain uninformed of their risk of carrying a cancer-associated pathogenic variant. Even among those informed, fewer than half subsequently complete genetic testing, representing a critical missed opportunity for precision cancer prevention. Innovation: Five studies evaluating interventions to improve disclosure rates were generally ineffective. Urgent work is needed to elucidate barriers to relative disclosure by probands to develop targeted interventions that can optimize proband-mediated cascade genetic testing rates.
Keywords Disclosure ; Cascade genetic testing ; Hereditary cancer syndromes ; Lynch syndrome ; Hereditary breast and ovarian cancer ; Public aspects of medicine ; RA1-1270
Language English
Publishing date 2023-12-01T00:00:00Z
Publisher Elsevier
Document type Article ; Online
Database BASE - Bielefeld Academic Search Engine (life sciences selection)

More links

Kategorien

To top